Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 907304, 7 pages
http://dx.doi.org/10.1155/2015/907304
Clinical Study

The Impact of Thrombocytopenia on Outcome in Patients with Acute Coronary Syndromes: A Single Center Retrospective Study

1Department of Medical Intensive Care, University Clinical Center Maribor, Ljubljanska 5, SI-2000 Maribor, Slovenia
2Department of Hematology, University Clinical Center Maribor, Ljubljanska 5, SI-2000 Maribor, Slovenia

Received 1 May 2015; Accepted 14 July 2015

Academic Editor: Zsolt Molnár

Copyright © 2015 Andreja Sinkovič and Maja Majal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Lilly and R. L. Wilensky, “Emerging therapies for acute coronary syndromes,” Frontiers in Pharmacology, vol. 2, article 61, 2011. View at Publisher · View at Google Scholar
  2. P. G. Steg, S. K. James, D. Atar et al., “ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. W. Hamm, J.-P. Bassand, S. Agewall et al., “ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Caixeta, G. D. Dangas, R. Mehran et al., “Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial,” American Heart Journal, vol. 161, no. 2, pp. 298.e1–306.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Y. Wang, F.-S. Ou, M. T. Roe et al., “Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice,” Circulation, vol. 119, no. 18, pp. 2454–2462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Sekhon and V. Roy, “Thrombocytopenia in adults: a practical approach to evaluation and management,” Southern Medical Journal, vol. 99, no. 5, pp. 491–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. W. H. Matthai Jr., “Evaluation of thrombocytopenia in the acute coronary syndrome,” Current Opinion in Hematology, vol. 17, no. 5, pp. 398–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Gore, F. A. Spencer, E. P. Gurfinkel et al., “Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]),” The American Journal of Cardiology, vol. 103, no. 2, pp. 175–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. J. Topol, D. J. Moliterno, H. C. Herrmann et al., “Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization,” The New England Journal of Medicine, vol. 344, no. 25, pp. 1888–1894, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Merlini, M. Rossi, A. Menozzi et al., “Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting,” Circulation, vol. 109, no. 18, pp. 2203–2206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Taniuchi, H. I. Kurz, and J. M. Lasala, “Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population,” Circulation, vol. 104, no. 5, pp. 539–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. De Labriolle, L. Bonello, G. Lemesle et al., “Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors,” European Heart Journal, vol. 31, no. 9, pp. 1079–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. W. Stone, B. Witzenbichler, G. Guagliumi et al., “Bivalirudin during primary PCI in acute myocardial infarction,” The New England Journal of Medicine, vol. 358, no. 21, pp. 2218–2230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. E. Warkentin and M. A. Crowther, “Adverse prognostic significance of thrombocytopenia in acute coronary syndrome: can anything be done about it?” Circulation, vol. 119, no. 18, pp. 2420–2422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. A. Naqvi, N. Ikhlaque, and M. A. Baumann, “Thrombocytopenia due to hypotension unrelated to infection: shock marrow,” International Journal of Clinical Practice, vol. 59, no. 7, pp. 782–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Roy, E. W. Howard, J. A. Panza, and H. A. Cooper, “Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit,” Clinical Cardiology, vol. 33, no. 1, pp. 30–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Mehran, S. V. Rao, D. L. Bhatt et al., “Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium,” Circulation, vol. 123, no. 23, pp. 2736–2747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Bagshaw, C. George, R. Bellomo, and ANZICS Database Management Committe, “A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients,” Nephrology Dialysis Transplantation, vol. 23, no. 5, pp. 1569–1574, 2008. View at Google Scholar
  20. C. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman, and H. D. White, “Third universal definition of myocardial infarction,” European Heart Journal, vol. 33, no. 20, pp. 2551–2567, 2012. View at Publisher · View at Google Scholar
  21. M. W. Tempelhof, K. H. Benzuly, D. Fintel, and M. Z. Krichavsky, “Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty,” Texas Heart Institute Journal, vol. 39, no. 1, pp. 86–91, 2012. View at Google Scholar · View at Scopus
  22. A. H. Gershlick, J. N. Khan, D. J. Kelly et al., “Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial,” Journal of the American College of Cardiology, vol. 65, no. 10, pp. 963–972, 2015. View at Publisher · View at Google Scholar
  23. D. J. Kereiakes and P. A. Gurbel, “Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention,” JACC: Cardiovascular Interventions, vol. 1, no. 2, pp. 111–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Mueller, F.-J. Neumann, W. Hochholzer et al., “The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction,” American Heart Journal, vol. 151, no. 6, pp. 1214.e1–1214.e7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. NICE Clinical Guideline Center and Royal College of Physician, “Myocardial infarction with ST-segment elevation: the acute management of myocardial infarction with ST-segment elevation,” in NICE Clinical Guideline 167, Methods, Evidence and Recommendations, NICE Clinical Guideline Center, Royal College of Physician, London, UK, 2013, https://www.nice.org.uk/guidance/cg167. View at Google Scholar